279 related articles for article (PubMed ID: 31636100)
21. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.
Kern DE; Kidd PG; Moe R; Hanke D; Olerud JE
Arch Dermatol; 1998 Feb; 134(2):158-64. PubMed ID: 9487207
[TBL] [Abstract][Full Text] [Related]
22. Response and local control in patients treated with low-dose radiotherapy for tumoral mycosis fungoides.
Pena J; Cull D; Strowd LC; Vaidya R; Seegars MB; Ahn C; Winkfield KM; Hughes RT
Leuk Lymphoma; 2023 Dec; 64(13):2202-2207. PubMed ID: 37671707
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation.
Maingon P; Truc G; Dalac S; Barillot I; Lambert D; Petrella T; Naudy S; Horiot JC
Radiother Oncol; 2000 Jan; 54(1):73-8. PubMed ID: 10719702
[TBL] [Abstract][Full Text] [Related]
24. Tumor-stage mycosis fungoides of the vulva successfully treated with local low-dose radiotherapy.
Bakar Ö; Şahin S; Çetinözman F; Willemze R; Tezcanli E; Çetin ED
Dermatol Ther; 2015; 28(1):36-9. PubMed ID: 25314306
[TBL] [Abstract][Full Text] [Related]
25. Palliative local radiotherapy in the treatment of tumor-stage cutaneous T-cell lymphoma/mycosis fungoides.
Xu CC; Zhang T; Wang T; Liu J; Liu YH
Chin Med Sci J; 2014 Mar; 29(1):33-7. PubMed ID: 24698676
[TBL] [Abstract][Full Text] [Related]
26. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
27. Total Skin Electron Beam Therapy with Rotary Dual Technique as Palliative Treatment for Mycosis Fungoides.
Piotrowski T; Fundowicz M; Pawlaczyk M
In Vivo; 2018; 32(3):517-522. PubMed ID: 29695554
[TBL] [Abstract][Full Text] [Related]
28. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
[TBL] [Abstract][Full Text] [Related]
29. Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides.
Foss F; Duvic M; Lerner A; Waksman J; Whittaker S
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):637-643. PubMed ID: 27637428
[TBL] [Abstract][Full Text] [Related]
30. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
31. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
32. Total skin electron irradiation in mycosis fungoides dose and fractionation considerations.
Rosenblatt E; Kuten A; Leviov M; Cederbaum M
Leuk Lymphoma; 1998 Jun; 30(1-2):143-51. PubMed ID: 9669684
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
[TBL] [Abstract][Full Text] [Related]
34. The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.
Morris S; Scarisbrick J; Frew J; Irwin C; Grieve R; Humber C; Kuciejewska A; Bayne S; Weatherhead S; Child F; Wain M; Whittaker S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):627-633. PubMed ID: 28843374
[TBL] [Abstract][Full Text] [Related]
35. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
36. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
[TBL] [Abstract][Full Text] [Related]
37. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoides.
Amorim GM; Corbellini JPN; Quintella DC; Cuzzi T; Ramos-E-Silva M
An Bras Dermatol; 2018; 93(5):680-685. PubMed ID: 30156617
[TBL] [Abstract][Full Text] [Related]
39. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
40. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
